Cited by 322Acute Kidney Injury ResearchInflammatory mediators and NSAID effectsNephrotoxicity and Medicinal Plants

Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies

Ungprasert, Patompong, Cheungpasitporn, Wisit, Crowson, Cynthia S., Matteson, Eric L.·2015·European Journal of Internal Medicine

Abstract

Background The association between acute kidney injury (AKI) and use of non-steroidal anti-inflammatory drugs (NSAIDs) is well established. However, little is known about the comparative risk of individual NSAIDs, including specific COX-2 inhibitors. Methods We conducted a systematic review and meta-analysis of cohort studies that reported relative risk, hazard ratio or standardized incidence ratio with 95% confidence comparing AKI risk in NSAID users versus non-users. Pooled risk ratios and 95% confidence intervals for individual NSAIDs were calculated using random-effect, generic inverse variance methods. Results Five studies were identified and included in our data analysis. Pooled risk ratios were calculated for seven traditional NSAIDs and two specific COX-2 inhibitors, including indomethacin, piroxicam, ibuprofen, naproxen, sulindac, diclofenac, meloxicam, rofecoxib and celecoxib that were evaluated in at least two studies. Our meta-analysis was able to demonstrate a statistically significant elevated AKI risk among most of the included traditional NSAIDs. The pooled risk ratios were fairly consistent among individual traditional NSAIDs, ranging from 1.58 to 2.11. Differences between pooled risk ratios did not reach statistical significance (p≥0.19 for each comparison). Elevated AKI risk was also observed in diclofenac, meloxicam, rofecoxib and celecoxib users, although did not achieve a statistical significance. Conclusion A statistically significant elevated AKI risk among traditional NSAID users has been demonstrated in this meta-analysis. The pooled risk ratios among individual traditional NSAIDs were not significantly different. The pooled risk ratios of specific COX-2 inhibitors and the two traditional NSAIDs with the most COX-2 selectivity (diclofenac and meloxicam) were also comparable with other traditional NSAIDs even though they did not achieve a statistical significance.

Integrity signals

Registry

Crossref · 10.1016/j.ejim.2015.03.008

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The inference that acute inflammation usually has positive effects is strongly supported by findings that inhibiting the inflammatory response by nonsteroidal anti-inflammatory drugs worsens wound and bone healing, increases the risk of anastomotic failure or sepsis after surgery, aggravates heart and renal failure, interferes with an adequate immune response to antigen presentation in the gut, or

    “The inference that acute inflammation usually has positive effects is strongly supported by the finding that inhibiting the inflammatory response by nonsteroidal anti‐inflammatory drugs worsens wound and bone healing,47, 48, 49, 50 increases the risk of anastomotic failure or sepsis after surgery,51, 52 aggravates heart and renal failure,53, 54 interferes with an adequate immune response to”

    From Hypoalbuminemia: Pathogenesis and Clinical Significance (2019) · cites this paper as [53]

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 40 · Cited by 322

Authors
Ungprasert, P., Cheungpasitporn, W., Crowson, C. S., & Matteson, E. L.
Affiliations
Mayo Clinic (US)
Corresponding author
Ungprasert, Patompong
Venue
European Journal of Internal Medicine
Publisher
Elsevier BV
Published
2015-05
Volume
26
Issue
4
Pages
285-291
ISSN
0953-6205 (ISSN-L)
OpenAlex
W2121944063
Cited by
322
References
40
Citations by year
2026: 15 · 2025: 27 · 2024: 33 · 2023: 22 · 2022: 39 · 2021: 42 · 2020: 40 · 2019: 38 · 2018: 21 · 2017: 23 · 2016: 17 · 2015: 5
FWCI
3.47
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Nephrotoxicity and Medicinal Plants
Keywords
acute kidney injury, nonsteroidal anti-inflammatory drugs, COX-2 inhibitors, diclofenac, meloxicam, rofecoxib, celecoxib, ibuprofen, naproxen, piroxicam, sulindac, indomethacin, drug-induced nephrotoxicity
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Humans, Risk Factors, Odds Ratio, Cyclooxygenase 2 Inhibitors, Acute Kidney Injury, Observational Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review